Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × sargramostim × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 11 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡